New tools in regenerative medicine: Gene therapy

Advances in Experimental Medicine and Biology

Volumn 741, Issue , 2012, Pages 254-275

  Muñoz Ruiz, Miguel ^a   Regueiro, José R ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; HERPESVIRUS VECTOR; LENTIVIRUS VECTOR; PARVOVIRUS VECTOR; RETROVIRUS VECTOR;

ADENOSINE DEAMINASE DEFICIENCY; ADULT STEM CELL; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BIOSAFETY; CELL BASED GENE THERAPY; CYSTIC FIBROSIS; DUCHENNE MUSCULAR DYSTROPHY; EMBRYONIC STEM CELL; EX VIVO GENE TRANSFER; GENE THERAPY; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN SITU GENE THERAPY; IN VIVO GENE TRANSFER; MESENCHYMAL STEM CELL; NEURAL STEM CELL; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; SEVERE COMBINED IMMUNODEFICIENCY; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; X CHROMOSOME LINKED DISORDER;

CLINICAL TRIALS AS TOPIC; GENE THERAPY; GENETIC VECTORS; HUMANS; REGENERATIVE MEDICINE; STEM CELLS; TRANSGENES;

IPS;

EID: 84859790300     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-2098-9_17     Document Type: Article

References (32)

1. Jopling C, Boue S, Izpisua Belmonted JC. Dedifferentiation, transdifferentiation and reprogramming: Three routes to regeneration. Nat Rev Mol Cell Biol. 2011 Feb;12(2):79-89.
2. Noguchi P. Risks and benefits of gene therapy. N Engl J Med 2003; 348:193-194. (Pubitemid 36077913)
3. Urnov FD, Miller JC, Lee YL et al. Highly efficient endogenous human gene couection using designed zinc-finger nucleases. Nature 2005; 435:646-65 1. (Pubitemid 40825505)
4. Chan PP, Glazer PM. Triplex DNA: Fundamentals, advances, and potential applications for gene therapy. J Mol Med 1997; 75:267-282. (Pubitemid 27209976)
5. Berns A. Good news for gene therapy. N Engl J Med 2004; 350(16):1679-1680. (Pubitemid 38501171)
6. Gene therapy progress and prospects. Special tissue. Gene Ther 2004; 11.
7. Räty JK, Lesch HP, Wirth T et al. Improving safety of gene therapy. Curr Drug Saf 2008; 3(1):46-53. (Pubitemid 351223153)
8. Douglas KL. Toward development of artificial vimses for gene therapy: A comparative evaluation of viral and non-viral transfection. Biotechnol Prog 2008; 24:871-883.
9. Foldvari M, Babiuk S, Badea I. DNA delivery for vaccination and therapeutics through the skin. Curr Drug Deliv 2006; 3(1):17-28.
10. Acsadi G, Dickson G, Love DR et al. Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature 1991; 29:757-758.
11. Ahrlund-Richter L, De Luca M, Marshak DR et al. Isolation and production of cells suitable for human therapy: Challenges ahead. Cell Stem Cell 2009; 4:20-26.
12. Cuende N, Izeta A. Clinical translation of stem cell therapies: A bridgeable gap. Cell Stem Cell 2010; 6(6):508-512.
13. Alexander BL, Ali RR, Alton EW et al. Progress and prospects: Gene therapy clinical trials (part 1). Gene Ther 2007; 14(20):1439-1447.
14. Gatti RA, Meuwissen HJ, Allen HD et al. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 1968; 2:1366-1369.
15. Unger C, Kärner E, Treschow A et al. Lentiviral-mediated HoxB4 expression in human embryonic stem cells initiates early hematopoiesis in a dose-dependent manner but does not promote myeloid differentiation. Stem Cells. 2008; 26:2455-2466.
16. Takahashi K, Tanabe K, Obnuki Metal. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131:861-872. (Pubitemid 350138099)
17. Hadjantonakis A, Papaioannou V. The stem cells of early embryos. Differentiation 2001; 68:159-166. (Pubitemid 33754988)
18. Kucerova L, Altanerova V, Matuskova M et al. Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Research. 2007; 67:6304-6313. (Pubitemid 47037513)
19. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284(5411):143-147. (Pubitemid 29282067)
20. Kumar S, Chanda D, Posmazbagan S. Therapeutic potential of genetically modified mesenchymal stem cells. Gene Ther 2008; 15(10):71 1-715. (Pubitemid 351627354)
21. Strom S, Fisher R. Hepatocyte transplantation: New possibilities for therapy. Gastroenterology 2003; 124:568-571. (Pubitemid 36169272)
22. Rideout WM 3rd, Hochedlinger K, Kyba M et al. Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell 2002; 109:17-27. (Pubitemid 34327513)
23. Ott MG, Schmidt M, Schwarzwaelder K et al. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med 2006; 12 :401-409.
24. Podsakoff GM, Engel BC, Carbonaro DA et al. Selective survival of peripheral blood lymphocytes in children with HIV-1 following delivery of an anti-HIV gene to bone marrow CD34(?) cells. Mol Ther 2005; 12:77-86. (Pubitemid 40862359)
25. Weiss ML, Troyer DL. Stem cells in the umbilical cord. Stem Cell Rev 2006; 2:155-162. Review. (Pubitemid 46137576)
26. Le Blanc K, Rasmusson I, Sundberg B et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363:1439-1441. (Pubitemid 38586721)
27. Studeny M, Marini FC, Dembinski JL et al. Mesenchymal stem cells: Potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 2004; 96:1593-1603. (Pubitemid 39534883)
28. Kumar S, Ponnazhagan S. Bone homing of mesenchymal stem cells by ectopic alpha 4 integrin expression. FASEB J 2007; 21:3917-3927. (Pubitemid 350232349)
29. Hachiya A, Sriwiriyanont P, Patel A et al. Gene transfer in human skin with different pseudotyped HIV-based vectors. Gene Ther 2007; 14:648-656. (Pubitemid 46585624)
30. Mavilio F, Pellegrini G, Fenad S et al. Convction ofjunctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat Mcd 2006; 12:1397-1402. (Pubitemid 44924498)
31. Raya A, Rodriguez-Piza I, Guenechea G et al. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 2009; 460:53-59.
32. Sun N, Longaker MT, Wu JC. Human iPS cell-based therapy. Considerations before clinical applications. Cell Cycle 2010; 9:880-885.